» Articles » PMID: 31191201

Novel Mutations and Unreported Clinical Features in KBG Syndrome

Overview
Journal Mol Syndromol
Date 2019 Jun 14
PMID 31191201
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

KBG syndrome is an autosomal dominant disorder caused by pathogenic variants within or deletions of 16q24.3 which include . It is characterized by distinctive facial features, developmental delay, short stature, and skeletal anomalies. We report 12 unrelated patients where a clinical diagnosis of KBG was suspected and confirmed by targeted analyses. Nine patients showed a point mutation in (none of which were previously reported) and 3 carried a 16q24.3 deletion. All patients presented with typical facial features and macrodontia. Skeletal abnormalities were constant, and the majority of patients showed joint stiffness. Three patients required growth hormone treatment with a significant increase of height velocity. Brain malformations were identified in 8 patients. All patients showed behavioral abnormalities and most had developmental delay. Two patients had hematological abnormalities. We emphasize that genetic analysis of can easily reach a detection rate higher than 50% thanks to clinical phenotyping, although it is known that a subset of -mutated patients show very mild features and will be more easily identified through the implementation of gene panels or exome sequencing. Joint stiffness was reported previously in few patients, but it seems to be a common feature and can be helpful for the diagnosis. Hematological abnormalities could be present and warrant a specific follow-up.

Citing Articles

Insights into the ANKRD11 variants and short-stature phenotype through literature review and ClinVar database search.

He D, Zhang M, Li Y, Liu F, Ban B Orphanet J Rare Dis. 2024; 19(1):292.

PMID: 39135054 PMC: 11318275. DOI: 10.1186/s13023-024-03301-y.


GestaltMML: Enhancing Rare Genetic Disease Diagnosis through Multimodal Machine Learning Combining Facial Images and Clinical Texts.

Wu D, Yang J, Liu C, Hsieh T, Marchi E, Blair J ArXiv. 2024; .

PMID: 38711434 PMC: 11071539.


Olfactory bulb anomalies in KBG syndrome mouse model and patients.

Goodkey K, Wischmeijer A, Perrin L, Watson A, Qureshi L, Cordelli D BMC Med. 2024; 22(1):158.

PMID: 38616269 PMC: 11017579. DOI: 10.1186/s12916-024-03363-6.


Identification of Two Novel Mutations: Highlighting Incomplete Penetrance in KBG Syndrome.

Amllal N, Elalaoui S, Zerkaoui M, Chiguer A, Afif L, Izgua A Ann Lab Med. 2023; 44(1):110-117.

PMID: 37665295 PMC: 10485853. DOI: 10.3343/alm.2024.44.1.110.


Deep phenotyping of the neuroimaging and skeletal features in KBG syndrome: a study of 53 patients and review of the literature.

Peluso F, Caraffi S, Contro G, Valeri L, Napoli M, Carboni G J Med Genet. 2023; 60(12):1224-1234.

PMID: 37586838 PMC: 10715526. DOI: 10.1136/jmg-2023-109141.


References
1.
Herrmann J, PALLISTER P, Tiddy W, Opitz J . The KBG syndrome-a syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies. Birth Defects Orig Artic Ser. 1975; 11(5):7-18. View

2.
Zhang A, Yeung P, Li C, Tsai S, Dinh G, Wu X . Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators. J Biol Chem. 2004; 279(32):33799-805. DOI: 10.1074/jbc.M403997200. View

3.
Tekin M, Kavaz A, Berberoglu M, Fitoz S, Ekim M, Ocal G . The KBG syndrome: confirmation of autosomal dominant inheritance and further delineation of the phenotype. Am J Med Genet A. 2004; 130A(3):284-7. DOI: 10.1002/ajmg.a.30291. View

4.
Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L . Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006; 29(7):581-93. DOI: 10.1007/BF03344156. View

5.
Skjei K, Martin M, Slavotinek A . KBG syndrome: report of twins, neurological characteristics, and delineation of diagnostic criteria. Am J Med Genet A. 2007; 143A(3):292-300. DOI: 10.1002/ajmg.a.31597. View